VLDLR and atherosclerosis: IL-1α has been shown to promote atherosclerosis development as both atherosclerosis-prone apolipoprotein E (Apoe)- and low-density lipoprotein receptor (Ldlr)-deficient mice reconstituted with IL-1α-deficient bone marrow demonstrated a significant reduction of atherosclerotic lesions [17,19].